| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Apolipoproteins E | 12 | 2022 | 137 | 2.080 |
Why?
|
| Endothelial Cells | 9 | 2022 | 324 | 1.930 |
Why?
|
| Catalase | 16 | 2016 | 111 | 1.360 |
Why?
|
| Apolipoproteins B | 2 | 2022 | 18 | 1.350 |
Why?
|
| ATP-Binding Cassette Transporters | 5 | 2022 | 83 | 1.340 |
Why?
|
| Macrophages | 5 | 2016 | 515 | 1.050 |
Why?
|
| Lipoproteins, HDL | 3 | 2022 | 48 | 1.000 |
Why?
|
| Superoxide Dismutase | 15 | 2012 | 158 | 1.000 |
Why?
|
| Aorta | 17 | 2016 | 197 | 0.880 |
Why?
|
| Cholesterol | 10 | 2015 | 230 | 0.870 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 2 | 2015 | 16 | 0.840 |
Why?
|
| Serine Endopeptidases | 2 | 2015 | 48 | 0.830 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2015 | 78 | 0.810 |
Why?
|
| Apolipoprotein A-I | 2 | 2022 | 24 | 0.790 |
Why?
|
| Mice | 39 | 2022 | 6490 | 0.790 |
Why?
|
| Endothelium, Vascular | 5 | 2018 | 261 | 0.730 |
Why?
|
| Nerve Tissue Proteins | 2 | 2015 | 382 | 0.700 |
Why?
|
| Sp1 Transcription Factor | 5 | 2012 | 49 | 0.650 |
Why?
|
| Atherosclerosis | 3 | 2015 | 164 | 0.600 |
Why?
|
| Gene Expression Regulation | 4 | 2019 | 1066 | 0.590 |
Why?
|
| Lipoproteins | 2 | 2015 | 68 | 0.580 |
Why?
|
| Receptors, LDL | 3 | 2015 | 40 | 0.570 |
Why?
|
| Up-Regulation | 6 | 2014 | 534 | 0.570 |
Why?
|
| Animals | 44 | 2022 | 16695 | 0.550 |
Why?
|
| Aortic Diseases | 2 | 2009 | 34 | 0.520 |
Why?
|
| Signal Transduction | 7 | 2015 | 2111 | 0.520 |
Why?
|
| LDL-Receptor Related Proteins | 2 | 2015 | 10 | 0.490 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2016 | 297 | 0.480 |
Why?
|
| Response Elements | 2 | 2013 | 55 | 0.440 |
Why?
|
| Mice, Transgenic | 15 | 2016 | 658 | 0.420 |
Why?
|
| Mice, Knockout | 15 | 2014 | 1010 | 0.400 |
Why?
|
| Lipoproteins, LDL | 6 | 2018 | 66 | 0.380 |
Why?
|
| Antioxidants | 8 | 2009 | 439 | 0.380 |
Why?
|
| Apolipoprotein E4 | 1 | 2012 | 62 | 0.370 |
Why?
|
| Glutathione Peroxidase | 7 | 2007 | 100 | 0.370 |
Why?
|
| Reactive Oxygen Species | 5 | 2009 | 518 | 0.330 |
Why?
|
| Hydrogen Peroxide | 7 | 2010 | 193 | 0.330 |
Why?
|
| Cell Line | 5 | 2016 | 1416 | 0.330 |
Why?
|
| Ketocholesterols | 2 | 2007 | 4 | 0.320 |
Why?
|
| Lysophosphatidylcholines | 2 | 2007 | 22 | 0.320 |
Why?
|
| Lipids | 5 | 2012 | 256 | 0.310 |
Why?
|
| Cells, Cultured | 11 | 2018 | 1617 | 0.300 |
Why?
|
| Foam Cells | 4 | 2012 | 16 | 0.290 |
Why?
|
| Arteriosclerosis | 3 | 2005 | 42 | 0.280 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 599 | 0.280 |
Why?
|
| Benzo(a)pyrene | 4 | 2016 | 128 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 11 | 2016 | 1804 | 0.270 |
Why?
|
| Receptors, Aryl Hydrocarbon | 4 | 2012 | 49 | 0.270 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2004 | 31 | 0.260 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2004 | 58 | 0.260 |
Why?
|
| Aging | 4 | 2004 | 764 | 0.240 |
Why?
|
| Cell Communication | 2 | 2004 | 110 | 0.240 |
Why?
|
| Cell Adhesion | 4 | 2009 | 237 | 0.230 |
Why?
|
| Oxidative Stress | 7 | 2013 | 990 | 0.220 |
Why?
|
| Caloric Restriction | 1 | 2004 | 34 | 0.210 |
Why?
|
| Cholecystokinin | 2 | 2014 | 16 | 0.210 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 188 | 0.210 |
Why?
|
| Lipid Peroxidation | 4 | 2009 | 141 | 0.200 |
Why?
|
| Phosphorylation | 5 | 2015 | 973 | 0.200 |
Why?
|
| Cell Survival | 2 | 2006 | 934 | 0.200 |
Why?
|
| Leukocytes | 1 | 2003 | 79 | 0.200 |
Why?
|
| Vasoconstrictor Agents | 1 | 2003 | 42 | 0.200 |
Why?
|
| Activin Receptors | 1 | 2022 | 2 | 0.190 |
Why?
|
| Caveolae | 1 | 2022 | 10 | 0.190 |
Why?
|
| Receptors, Scavenger | 1 | 2022 | 15 | 0.190 |
Why?
|
| Nitric Oxide | 2 | 2012 | 381 | 0.190 |
Why?
|
| Apolipoprotein E3 | 2 | 2012 | 11 | 0.190 |
Why?
|
| Coronary Vessels | 1 | 2022 | 92 | 0.180 |
Why?
|
| Apolipoprotein B-48 | 2 | 2013 | 7 | 0.180 |
Why?
|
| Protein Kinase C | 2 | 2012 | 124 | 0.170 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 235 | 0.170 |
Why?
|
| Humans | 14 | 2022 | 42163 | 0.170 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2012 | 89 | 0.170 |
Why?
|
| Ethanol | 2 | 2013 | 221 | 0.160 |
Why?
|
| Hypercholesterolemia | 2 | 2014 | 42 | 0.160 |
Why?
|
| Blotting, Western | 6 | 2012 | 884 | 0.160 |
Why?
|
| Running | 1 | 2019 | 13 | 0.160 |
Why?
|
| Cerebrovascular Circulation | 1 | 2019 | 72 | 0.150 |
Why?
|
| Blood Pressure | 1 | 2003 | 662 | 0.150 |
Why?
|
| Plicamycin | 3 | 2011 | 9 | 0.130 |
Why?
|
| Microsomes, Liver | 1 | 2016 | 71 | 0.120 |
Why?
|
| Calpain | 1 | 2016 | 35 | 0.120 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 131 | 0.120 |
Why?
|
| Monocytes | 2 | 2009 | 275 | 0.120 |
Why?
|
| Heterozygote | 4 | 2013 | 107 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 683 | 0.120 |
Why?
|
| Hepatic Stellate Cells | 2 | 2013 | 6 | 0.120 |
Why?
|
| Culture Media, Conditioned | 1 | 2015 | 49 | 0.120 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2015 | 8 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 456 | 0.120 |
Why?
|
| RNA, Messenger | 5 | 2013 | 1265 | 0.120 |
Why?
|
| Intestinal Absorption | 1 | 2014 | 22 | 0.110 |
Why?
|
| Triglycerides | 4 | 2012 | 146 | 0.110 |
Why?
|
| Models, Biological | 2 | 2019 | 711 | 0.110 |
Why?
|
| Binding Sites | 1 | 2015 | 670 | 0.100 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2013 | 4 | 0.100 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2013 | 3 | 0.100 |
Why?
|
| Hepatocytes | 1 | 2013 | 79 | 0.100 |
Why?
|
| Cholagogues and Choleretics | 1 | 2012 | 3 | 0.100 |
Why?
|
| Endocytosis | 1 | 2013 | 117 | 0.100 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2004 | 142 | 0.100 |
Why?
|
| Central Nervous System Depressants | 1 | 2013 | 42 | 0.100 |
Why?
|
| Hypertriglyceridemia | 1 | 2012 | 16 | 0.100 |
Why?
|
| Pylorus | 1 | 2012 | 4 | 0.100 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2004 | 246 | 0.090 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2011 | 12 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2012 | 57 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2011 | 462 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 2 | 2016 | 254 | 0.090 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2011 | 18 | 0.090 |
Why?
|
| Apoptosis | 3 | 2006 | 1541 | 0.090 |
Why?
|
| Disease Models, Animal | 4 | 2012 | 1554 | 0.080 |
Why?
|
| Male | 13 | 2019 | 22779 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2013 | 267 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 206 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2003 | 167 | 0.080 |
Why?
|
| F2-Isoprostanes | 2 | 2009 | 20 | 0.080 |
Why?
|
| Acceleration | 1 | 1989 | 3 | 0.080 |
Why?
|
| G1 Phase | 1 | 2009 | 33 | 0.080 |
Why?
|
| Chemical Warfare Agents | 1 | 2009 | 14 | 0.080 |
Why?
|
| DNA Damage | 2 | 2001 | 358 | 0.080 |
Why?
|
| Lung Injury | 1 | 2009 | 18 | 0.080 |
Why?
|
| S Phase | 1 | 2009 | 37 | 0.080 |
Why?
|
| Mustard Gas | 1 | 2009 | 35 | 0.070 |
Why?
|
| Myocardial Contraction | 1 | 1989 | 46 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 1 | 2009 | 84 | 0.070 |
Why?
|
| 2-Aminopurine | 1 | 2008 | 10 | 0.070 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2008 | 18 | 0.070 |
Why?
|
| Macrophages, Peritoneal | 1 | 2008 | 23 | 0.070 |
Why?
|
| Liposomes | 1 | 2009 | 130 | 0.070 |
Why?
|
| Caspases | 2 | 2006 | 148 | 0.070 |
Why?
|
| Hypertension | 2 | 2006 | 823 | 0.070 |
Why?
|
| Hydrolases | 1 | 2007 | 15 | 0.070 |
Why?
|
| Lung | 2 | 2009 | 484 | 0.070 |
Why?
|
| Heart Rate | 1 | 1989 | 261 | 0.070 |
Why?
|
| Heart | 1 | 1989 | 181 | 0.070 |
Why?
|
| Bone Substitutes | 1 | 2007 | 3 | 0.070 |
Why?
|
| Skull Fractures | 1 | 2007 | 5 | 0.070 |
Why?
|
| Bioprosthesis | 1 | 2007 | 6 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2008 | 140 | 0.070 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2007 | 27 | 0.070 |
Why?
|
| Lysosomes | 1 | 2007 | 88 | 0.060 |
Why?
|
| Anthozoa | 1 | 2007 | 24 | 0.060 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2006 | 10 | 0.060 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2007 | 72 | 0.060 |
Why?
|
| Cell Shape | 1 | 2006 | 42 | 0.060 |
Why?
|
| Necrosis | 1 | 2006 | 54 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2006 | 226 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2007 | 214 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 205 | 0.060 |
Why?
|
| Liver | 4 | 2005 | 503 | 0.060 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2004 | 4 | 0.060 |
Why?
|
| Enzyme Induction | 1 | 2004 | 53 | 0.060 |
Why?
|
| Free Radical Scavengers | 2 | 2009 | 63 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 293 | 0.050 |
Why?
|
| Free Radicals | 1 | 2003 | 72 | 0.050 |
Why?
|
| Calcium | 1 | 2006 | 487 | 0.050 |
Why?
|
| Cytochrome P-450 CYP1A1 | 2 | 2016 | 52 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2004 | 92 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 222 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 239 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2003 | 110 | 0.050 |
Why?
|
| Organ Specificity | 2 | 2019 | 141 | 0.050 |
Why?
|
| Angiotensin II | 1 | 2003 | 103 | 0.050 |
Why?
|
| Deoxyribonuclease (Pyrimidine Dimer) | 1 | 2001 | 2 | 0.050 |
Why?
|
| Gene Expression | 3 | 2015 | 692 | 0.050 |
Why?
|
| Oxidation-Reduction | 4 | 2007 | 448 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 557 | 0.040 |
Why?
|
| Mitochondria, Heart | 1 | 2001 | 60 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 436 | 0.040 |
Why?
|
| Escherichia coli Proteins | 1 | 2001 | 133 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 129 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 534 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 303 | 0.030 |
Why?
|
| Rabbits | 2 | 2007 | 292 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2008 | 223 | 0.030 |
Why?
|
| Computational Biology | 1 | 2019 | 324 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 1998 | 173 | 0.030 |
Why?
|
| Gastric Mucosa | 2 | 2012 | 64 | 0.030 |
Why?
|
| DNA Repair | 1 | 1998 | 196 | 0.030 |
Why?
|
| Xenobiotics | 1 | 2016 | 14 | 0.030 |
Why?
|
| Peroxides | 1 | 2016 | 21 | 0.030 |
Why?
|
| Time Factors | 3 | 2007 | 1848 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2016 | 79 | 0.030 |
Why?
|
| Age Factors | 1 | 2019 | 1139 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2016 | 108 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2015 | 55 | 0.030 |
Why?
|
| Biological Transport | 1 | 2015 | 201 | 0.030 |
Why?
|
| Receptor, Cholecystokinin B | 1 | 2014 | 8 | 0.030 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2014 | 13 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2014 | 59 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2007 | 452 | 0.030 |
Why?
|
| Chloroquine | 1 | 2013 | 19 | 0.030 |
Why?
|
| Intestines | 1 | 2014 | 71 | 0.030 |
Why?
|
| Endosomes | 1 | 2013 | 34 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2007 | 686 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2014 | 98 | 0.030 |
Why?
|
| Mutation | 2 | 2011 | 1169 | 0.030 |
Why?
|
| Superoxides | 2 | 2004 | 57 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 295 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 94 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2013 | 92 | 0.020 |
Why?
|
| Apolipoproteins | 1 | 2012 | 22 | 0.020 |
Why?
|
| Cytosol | 2 | 2004 | 98 | 0.020 |
Why?
|
| Transfection | 2 | 2008 | 526 | 0.020 |
Why?
|
| Nitrergic Neurons | 1 | 2012 | 5 | 0.020 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2012 | 9 | 0.020 |
Why?
|
| Alleles | 1 | 2013 | 352 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 36 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1112 | 0.020 |
Why?
|
| Stomach | 1 | 2012 | 50 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2012 | 96 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2012 | 47 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 145 | 0.020 |
Why?
|
| Mice, Inbred DBA | 2 | 2001 | 72 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 574 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 602 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 88 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2014 | 548 | 0.020 |
Why?
|
| Female | 5 | 2012 | 24018 | 0.020 |
Why?
|
| Rats, Inbred F344 | 2 | 2001 | 256 | 0.020 |
Why?
|
| Amitrole | 1 | 2009 | 4 | 0.020 |
Why?
|
| Glutathione | 2 | 2001 | 170 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2009 | 25 | 0.020 |
Why?
|
| Barbital | 1 | 1989 | 1 | 0.020 |
Why?
|
| Strophanthins | 1 | 1989 | 1 | 0.020 |
Why?
|
| Ventricular Function | 1 | 1989 | 8 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2009 | 90 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2009 | 51 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 23 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 56 | 0.020 |
Why?
|
| Furans | 1 | 2009 | 39 | 0.020 |
Why?
|
| Pressure | 1 | 1989 | 49 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 2009 | 144 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 1989 | 198 | 0.020 |
Why?
|
| Myocardium | 2 | 2001 | 251 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 649 | 0.020 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2007 | 6 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 411 | 0.020 |
Why?
|
| Rats | 3 | 2001 | 3701 | 0.020 |
Why?
|
| Absorbable Implants | 1 | 2007 | 3 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2007 | 7 | 0.020 |
Why?
|
| Implants, Experimental | 1 | 2007 | 6 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2007 | 12 | 0.020 |
Why?
|
| Fracture Healing | 1 | 2007 | 4 | 0.020 |
Why?
|
| Skull | 1 | 2007 | 27 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2007 | 57 | 0.020 |
Why?
|
| Dinoprost | 1 | 2006 | 22 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2007 | 72 | 0.020 |
Why?
|
| Tissue Engineering | 1 | 2007 | 72 | 0.020 |
Why?
|
| Diet | 2 | 2002 | 810 | 0.010 |
Why?
|
| Ataxia Telangiectasia | 1 | 2005 | 7 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 522 | 0.010 |
Why?
|
| Zinc | 1 | 2006 | 130 | 0.010 |
Why?
|
| Copper | 1 | 2006 | 134 | 0.010 |
Why?
|
| Paraquat | 1 | 2004 | 21 | 0.010 |
Why?
|
| Gamma Rays | 1 | 2004 | 27 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 69 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2006 | 386 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 2004 | 57 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 103 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 105 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 100 | 0.010 |
Why?
|
| Models, Animal | 1 | 2004 | 149 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2004 | 97 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 136 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 2003 | 41 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2004 | 82 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2003 | 85 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 314 | 0.010 |
Why?
|
| Skin | 1 | 2004 | 185 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2009 | 1420 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2004 | 278 | 0.010 |
Why?
|
| Body Weight | 1 | 2004 | 428 | 0.010 |
Why?
|
| DNA-Formamidopyrimidine Glycosylase | 1 | 2001 | 2 | 0.010 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2001 | 7 | 0.010 |
Why?
|
| Aconitate Hydratase | 1 | 2001 | 7 | 0.010 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2001 | 6 | 0.010 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2001 | 10 | 0.010 |
Why?
|
| Sodium Iodide | 1 | 2001 | 4 | 0.010 |
Why?
|
| Endodeoxyribonucleases | 1 | 2001 | 29 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 2001 | 37 | 0.010 |
Why?
|
| Food Deprivation | 1 | 2001 | 33 | 0.010 |
Why?
|
| Oxidants | 1 | 2001 | 43 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2001 | 26 | 0.010 |
Why?
|
| Permeability | 1 | 2001 | 66 | 0.010 |
Why?
|
| Comet Assay | 1 | 2001 | 77 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 796 | 0.010 |
Why?
|
| Deoxyguanosine | 1 | 2001 | 37 | 0.010 |
Why?
|
| Energy Intake | 1 | 2002 | 162 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2001 | 111 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2001 | 230 | 0.010 |
Why?
|
| Species Specificity | 1 | 2001 | 279 | 0.010 |
Why?
|
| Food | 1 | 2001 | 102 | 0.010 |
Why?
|
| Mitochondria | 1 | 2004 | 516 | 0.010 |
Why?
|
| Glutathione Disulfide | 1 | 1999 | 8 | 0.010 |
Why?
|
| Pyrimidine Dimers | 1 | 1998 | 3 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1998 | 45 | 0.010 |
Why?
|
| Albumins | 1 | 1998 | 32 | 0.010 |
Why?
|
| Spleen | 1 | 1999 | 199 | 0.010 |
Why?
|
| DNA | 1 | 2001 | 594 | 0.010 |
Why?
|
| ras Proteins | 1 | 1998 | 54 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 1998 | 118 | 0.010 |
Why?
|
| Cats | 1 | 1998 | 80 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1998 | 148 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1999 | 308 | 0.010 |
Why?
|
| Kidney | 1 | 1999 | 363 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1998 | 301 | 0.010 |
Why?
|
| Base Sequence | 1 | 1998 | 997 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 1559 | 0.010 |
Why?
|
| Middle Aged | 1 | 2006 | 11819 | 0.010 |
Why?
|
| Brain | 1 | 1999 | 1452 | 0.010 |
Why?
|
| Adult | 1 | 2006 | 13458 | 0.010 |
Why?
|